Fecal Occult Testing Market Size

Fecal Occult Testing Market Size

Fecal Occult Testing Market size was worth USD 1 billion in 2022 and is poised to record substantial growth at 5.3% CAGR from 2023-2032, driven by the increasing prevalence of rectal & colon cancer.

Fecal occult testing, also referred to as fecal occult blood testing (FOBT), is a vital medical diagnostic procedure designed to identify minute quantities of concealed blood in stool samples. The existence of such concealed blood can serve as an indicative factor for various gastrointestinal (GI) conditions, encompassing colorectal cancer, polyps, ulcers, and other related disorders. This procedure involves the collection of a stool sample, followed by chemical reactions that reveal the presence of blood. Positive outcomes from this test lead to further diagnostic measures to pinpoint the underlying cause of the blood in the stool, thereby facilitating early detection and subsequent treatment.

The rising incidence of rectal and colon cancer is a significant driver for the market. Colorectal cancer is one of the most common cancers globally, and early detection plays a crucial role in improving patient outcomes. Fecal occult testing serves as a non-invasive and relatively simple method for detecting hidden traces of blood in the stool, which can be an early indicator of colorectal cancer. Furthermore, the growing preference for convenient and patient-friendly point-of-care testing (POCT) and non-invasive diagnostics has propelled fecal occult testing into prominence. Being non-invasive and easily conducted in clinics and primary care settings, fecal occult testing aligns perfectly with this trend. Its simple sample collection process and lack of specialized equipment needs make it ideal for point-of-care use. This upsurge in demand for non-invasive testing has consequently elevated fecal occult testing's adoption as a favored screening method.